Quest Diagnostics (DGX) Stock: Buy, Sell, or Hold?
DGX - Quest Diagnostics Inc.
$241.89
-1.39 (-0.57%)
▼
5d:
+2.93%
30d:
+2.24%
90d:
+4.33%
HOLD
MODERATE Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Oct 22, 2026
0d
Get Alerted When DGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DGX is fairly valued with market pricing in 3.7% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: DGX is fairly valued with market pricing in 3.7% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$286.43
Based on 5.8% avg growth
INTRINSIC VALUE TODAY
$177.85
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DGX is currently trading at $241.89, which is considered extended relative to its 30-day fair value range of $230.55 to $242.07. From a valuation perspective, the stock is trading at a premium (Forward PE: 20.1) compared to its historical average (18.0). At these levels, the market is pricing in 3.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, DGX is in a strong uptrend. The price is approaching resistance at $246.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DGX is in a strong uptrend. The price is approaching resistance at $246.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$230.55 -
$242.07
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.1%
Protect Your Profits
Holding DGX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (58/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($251.73)
- NEUTRAL: Market pricing in 3.7% annual earnings growth - fairly valued
- NEUTRAL: Bottoming setup forming (58/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$230.55 -
$242.07
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$223.50
Resistance Level
$246.00
Current Trend
Strong Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.10
Wall Street Target
$251.73
(+4.1%)
Revenue Growth (YoY)
10.2%
Earnings Growth (YoY)
15.0%
Profit Margin
9.2%
Valuation Premium vs History
+3.7% premium
PE vs Historical
20.1 vs 18.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.7%
(market-implied from PE analysis)
1-Year Target
$250.84
(+4%)
2-Year Target
$260.12
(+8%)
3-Year Target
$269.75
(+12%)
3-Yr Target (if PE normalizes)
(PE: 20→18)
PE COMPRESSION
$241.60
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 7.5%)
$300.38
(+24%)
Base:
(SPY PE: 19.9, Growth: 7.5%)
$296.84
(+23%)
Bear:
(PE: 16.9, Growth: 7.5%)
$252.32
(+4%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 25.36 | Current EPS (TTM): $9.42
Bull Case
$335.82
(+38%)
Analyst growth 27.8%, PE expands to 27.9
Base Case
$305.29
(+26%)
Market implied 27.8%, PE stable at 25.4
Bear Case
$162.47
(-33%)
Severe decline -20.0%, PE contracts to 21.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 23, 2026 5:51 PM ET
Data refreshes hourly during market hours. Next update: 6:51 PM
Data refreshes hourly during market hours. Next update: 6:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$202 | 67 BUY |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
28 analysts |
$691 | 48 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$404 | 54 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$244 | 45 HOLD |
Advanced DGX Option Strategies
Professional options setups generated by AI based on today's DGX price and gamma walls.
